CompletedNo phase
VEGF and Nailfold Changes in Psoriasis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Al-Azhar University
- Trial code
- NCT07925957
- Record updated
- 9 November 2026
- Original description
VEGF and Nailfold Changes in PsoriasisRead full original descriptionShow less
Correlation Between Serum Vascular Endothelial Growth Factor (VEGF) Levels and Nailfold Capillaroscopic Changes in Psoriatic Patients
VEGF and Nailfold Changes in Psoriasis
Inclusion: Patients diagnosed with psoriasis. Attending the Dermatology Outpatient Clinics at Al-Hussein University Hospital and Sayyid Galal University Hospital between September 2025 and March 2026.
Exclusion: Connective tissue diseases (e.g., systemic sclerosis, SLE). Diabetes mellitus or peripheral vascular disease. Smoking. Pregnancy. Recent use of vasodilators or beta-blockers. Manual workers with vibrating tools. -; -.